CELG

Celgene Corporation News Headlines

$93.85
*  
0.58
0.62%
Get CELG Alerts
*Delayed - data as of Sep. 19, 2014  -  Find a broker to begin trading CELG now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    CELG Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Survey Of The Pancreatic Cancer Drug Market With Celgene's Abraxane In Focus
11/11/2012 2:07:00 AM - Seeking Alpha

Loss at ITMN Narrower than Expected - Analyst Blog
11/8/2012 12:00:01 PM - Zacks.com

Threshold, Clovis and Celgene: An Update On Pancreatic Cancer Trials
11/7/2012 1:10:00 PM - Seeking Alpha

This Cheap BioPharma Has Further Upside Ahead
11/5/2012 11:22:00 AM - Seeking Alpha

5 Large Cap Stocks With Solid Profitability And Reserves
10/31/2012 11:36:00 AM - Seeking Alpha

Cramer's Lightning Round - Which Rail Will Win The Election? (10/29/12)
10/30/2012 6:56:00 AM - Seeking Alpha

Out of the Red and into the Black: John McCamant on Investment in Blood Cancer Companies
10/29/2012 8:59:00 AM - Trefis

Cramer's Mad Money - 14 Things To Watch In The Week Ahead (10/26/12)
10/28/2012 7:04:00 AM - Seeking Alpha

Out Of The Red And Into The Black: John McCamant On Investment In Blood Cancer Companies
10/25/2012 6:34:00 PM - Seeking Alpha

Sales Swell at Celgene - Analyst Blog
10/25/2012 12:41:01 PM - Zacks.com

Whisper Number Impact: Earnings Preview For Celgene And Biogen Idec
10/24/2012 8:17:00 PM - Seeking Alpha

Pre-Market Earnings Report for October 25, 2012 : PG, COP, OXY, MO, CL, SPG, POT, GG, DOW, NOV, BIIB, CELG
10/24/2012 4:09:22 PM - NASDAQ.com News

FDA Label Expansion for Abraxane - Analyst Blog
10/23/2012 2:20:01 PM - Zacks.com

Onyx Enrolls FOCUS Patients - Analyst Blog
10/22/2012 4:29:35 PM - Zacks.com

Cramer's 6 Favorite Stock Recommendations Have Outperformed The S&P 500 Handily
10/22/2012 11:20:00 AM - Seeking Alpha

Celgene: Was Abraxis Worth It?
10/15/2012 4:55:00 PM - Seeking Alpha

2 Biotech Stocks Ready To Flourish In The Wake Of Very Significant FDA News
10/14/2012 3:50:00 AM - Seeking Alpha

Celgene's Pipeline Offers Catalysts Into 2013
10/3/2012 6:33:00 PM - Seeking Alpha

Celgene's Abraxane Encourages - Analyst Blog
10/3/2012 5:36:01 PM - Zacks.com

Fly To Safety
10/2/2012 3:21:00 PM - Seeking Alpha

Cramer's Lightning Round - Devon Is A Disappointment (10/1/12)
10/2/2012 7:10:00 AM - Seeking Alpha

2.4% Yield And 10+ Potential Blockbuster Drugs
9/26/2012 10:05:00 AM - Seeking Alpha

Tracking The Investment Profile Of A Proven Winner
9/25/2012 8:53:00 AM - Seeking Alpha

Multi-Stage Pharmaceuticals With Investment Potential In The War On Cancer
9/24/2012 11:20:00 AM - Seeking Alpha

FDA Panel to Review Celgene Drug - Analyst Blog
9/20/2012 9:35:27 AM - Zacks.com